Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History CMMB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics CMMB

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Chemomab Therapeutics Ltd DRC

CMMB
Current price
1.15 USD -0.07 USD (-5.74%)
Last closed 1.16 USD
ISIN US16385C1045
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 22 230 008 USD
Yield for 12 month +12.75 %
1Y
3Y
5Y
10Y
15Y
CMMB
21.11.2021 - 28.11.2021

Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases in the United States. Its lead product candidate is Nebokitug, a humanized monoclonal antibody attenuates the basic function of CCL24 that has completed phase 2 clinical trial for the treatment of primary sclerosing cholangitis (PSC); and is in phase 2 clinical trial to treat systemic sclerosis (SSc). Chemomab Therapeutics Ltd. was founded in 2011 and is based in Tel Aviv, Israel. Address: Building 7, Tel Aviv, Israel, 6158002

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

8.50 USD

P/E Ratio

Dividend Yield

Financials CMMB

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures CMMB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

-66 827 USD

Current Quarter

Last Quarter

EBITDA -14 128 500 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -57.49 %
PEG Ratio
Return On Equity TTM -112.97 %
Wall Street Target Price 8.50 USD
Revenue TTM
Book Value 0.55 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.64 USD
Diluted Eps TTM -0.64 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation CMMB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 13.00
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 0.33
Price Book MRQ 2.14

Technical Indicators CMMB

For 52 Weeks

0.87 USD 2.55 USD
50 Day MA 1.28 USD
Shares Short Prior Month 66 042
200 Day MA 1.52 USD
Short Ratio 1.08
Shares Short 157 225
Short Percent 0.82 %